SCHEDULE 13G: Pacer Funds and Affiliates Disclose 7.32% Passive Stake in Ironwood Pharmaceuticals

Pacer US Small Cap Cash Cows ETF, Pacer Advisors, Inc., and Joe M. Thomson have jointly reported a passive beneficial ownership of 7.32% of Ironwood Pharmaceuticals Inc.'s Class A Common Stock as of December 31, 2024.

Summary

• The filing is a Schedule 13G, indicating beneficial ownership of more than 5% of Ironwood Pharmaceuticals Inc.'s Class A Common Stock.
• The reporting persons are Pacer US Small Cap Cash Cows ETF, Pacer US Small Cap Cash Cows Growth Leaders ETF, Pacer Advisors, Inc., and Joe M. Thomson.
• Collectively, the reporting persons beneficially own an aggregate of 11,730,771 shares of Ironwood Pharmaceuticals Inc. Class A Common Stock.
• This ownership represents 7.32% of the total Class A Common Stock outstanding, calculated based on 160,205,899 shares outstanding as of December 31, 2024.
• All reporting persons hold shared voting power and shared dispositive power over the 11,730,771 shares.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of a passive ownership stake and does not contain information that would indicate a positive or negative sentiment regarding the issuer's performance or prospects.

Future Outlook

NA

Industry Context

NA

Key Dates

Keywords

Ironwood Pharmaceuticals, Schedule 13G, Pacer US Small Cap Cash Cows ETF, Pacer Advisors, Joe M. Thomson, beneficial ownership, Class A Common Stock, passive investment, SEC filing